We make
more than

We make it better.

We are a fast-growing global pharmaceutical company that develops, manufactures and distributes generic, biosimilar and added-value medicines in over 85 countries worldwide, helping to improve access for patients to vital pharmaceutical care at the point of need.  

By challenging the status quo and directly addressing unmet clinical and societal needs, Accord continuously strives to make things better by delivering high quality medicines to patients, faster, more economically, reliably and with greater innovation than many other generic companies.

Accord's portfolio spans across critical therapeutic fields such as oncology, cardiology, neurology, psychiatry, diabetes, pain management and gastroenterology.

Accord, we make it better


End of Year Report 2021

We are one accord

Accord are continually looking for innovative ways to better support patients and the healthcare community – our agility and flexibility set us apart from other pharmaceutical companies.

Find out what we’ve been up to recently via our News & Media page

Accord develops, manufactures and distributes a broad range of essential medicines for hospital and retail pharmacies across Europe and the rest of the world.

Learn more about our products

Accord is one of the fastest growing generics and biosimilar pharmaceutical companies in the world – we welcome applications to join our talented team.

Constantly striving to be an exemplary corporate citizen by reducing our overall impact on the environment and, through inspirational partnerships, donating essential medicines around the world to people in need.